Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile (CoronaVarCL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05593042 |
|
Recruitment Status :
Recruiting
First Posted : October 25, 2022
Last Update Posted : January 13, 2023
|
Sponsor:
Pontificia Universidad Catolica de Chile
Collaborator:
Sinovac Life Sciences Co., Ltd.
Information provided by (Responsible Party):
Pontificia Universidad Catolica de Chile
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2023 |
| Estimated Study Completion Date : | September 2023 |